Adaptimmune Therapeutics plc (ADAP)
USD 0.61
(1.1%)
USD 0.61
(1.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -141.42 Million | -141.76 Million | 10.72 Million | -53.59 Million | -112.5 Million | -104.38 Million |
| Net Income | -114.31 Million | -165.45 Million | -158.09 Million | -130.09 Million | -137.16 Million | -95.51 Million |
| Depreciation & Amortization | 9.85 Million | 6.07 Million | 6.56 Million | 7.59 Million | 8.01 Million | 7.81 Million |
| Deferred income taxes | -41.9 Million | - | 5.81 Million | 2.5 Million | 1.06 Million | 12.22 Million |
| Stock-based compensation | 11.77 Million | 18.24 Million | 20.62 Million | 10.41 Million | 11.05 Million | - |
| Change in working capital | -25.04 Million | -1.53 Million | 134.63 Million | 56.04 Million | 4.71 Million | -45.34 Million |
| Other non-cash items | 18.21 Million | 903 Thousand | 1.17 Million | -55 Thousand | -185 Thousand | 237 Thousand |
| Investing Cash Flow | 177.22 Million | 89.13 Million | 75.8 Million | -278.92 Million | 94.94 Million | -17.45 Million |
| Investments in PPE | -4.89 Million | -29.74 Million | -8.78 Million | -2.9 Million | -3.07 Million | -4.7 Million |
| Acquisitions | 45.43 Million | 77.85 Million | 207 Thousand | 565 Thousand | 1.48 Million | 798 Thousand |
| Investment purchases | -76.24 Million | -48.11 Million | -139.76 Million | -381.04 Million | -27.28 Million | -150.78 Million |
| Sales/Maturities of investments | 211.8 Million | 166.99 Million | 224.34 Million | 105.02 Million | 125.3 Million | 138.03 Million |
| Other Investing Activities | 1.12 Million | -77.85 Million | -207 Thousand | -565 Thousand | -1.48 Million | -798 Thousand |
| Financing Cash Flow | 883.41 Thousand | 12.86 Million | 3.28 Million | 340.05 Million | 366 Thousand | 102.69 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 883.41 Thousand | 12.81 Million | 3.28 Million | 342.69 Million | 367.51 Thousand | 99.65 Million |
| Other Financing Activities | 256 Thousand | 50 Thousand | 3.28 Million | 340.05 Million | -1515.00 | 3.03 Million |
| Accounts receivables | -1.29 Million | -9.8 Million | -19.35 Million | 1.76 Million | -1.44 Million | - |
| Accounts payables | -9.12 Million | 4.4 Million | 4.2 Million | 3.89 Million | 7.63 Million | - |
| Inventory | -1.00 | 5.4 Million | 15.14 Million | -5.65 Million | -6.19 Million | - |
| Other working capital | -14.63 Million | -1.53 Million | 134.63 Million | 56.04 Million | 4.71 Million | -45.34 Million |
| Cash at beginning of period | 108.03 Million | 151.66 Million | 61.48 Million | 54.9 Million | 72.47 Million | 88.29 Million |
| Cash at end of period | 143.99 Million | 109.6 Million | 151.66 Million | 61.48 Million | 54.9 Million | 72.47 Million |
| Capital Expenditure | -4.89 Million | -29.74 Million | -8.78 Million | -2.9 Million | -3.07 Million | -4.7 Million |
| Effect of forex changes on cash | 877 Thousand | -2.29 Million | 365 Thousand | -960 Thousand | -372 Thousand | 3.33 Million |
| Net cash flow / Change in cash | 35.95 Million | -42.06 Million | 90.18 Million | 6.57 Million | -17.56 Million | -15.82 Million |
| Free Cash Flow | -146.32 Million | -171.5 Million | 1.94 Million | -56.49 Million | -115.58 Million | -109.09 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 69.59 Million | -48.47 Million | -48.33 Million | -114.31 Million | -45.6 Million | -21.38 Million |
| Depreciation & Amortization | 2.74 Million | 2.82 Million | 2.87 Million | 9.85 Million | 2.89 Million | 2.23 Million |
| Deferred income taxes | - | - | -10.71 Million | -41.9 Million | -630 Thousand | -931 Thousand |
| Stock-based compensation | 3.05 Million | 3.1 Million | 3.08 Million | 11.77 Million | 3.17 Million | 3.83 Million |
| Change in working capital | -27.35 Million | 10.35 Million | 28.41 Million | -25.04 Million | -4.69 Million | -5.88 Million |
| Other non-cash items | -5.95 Million | 1.05 Million | 10 Million | 18.21 Million | -304 Thousand | -21.62 Million |
| Investing Cash Flow | -743.54 Thousand | -357.79 Thousand | 68.4 Million | 177.22 Million | 57.3 Million | 2.69 Million |
| Investments in PPE | -754.55 Thousand | -357.79 Thousand | -828.01 Thousand | -4.89 Million | -289 Thousand | -1.24 Million |
| Acquisitions | - | - | -24.44 Thousand | 45.43 Million | -86.55 Thousand | 26 Thousand |
| Investment purchases | - | - | -2.89 Million | -76.24 Million | -5.9 Million | -67.12 Million |
| Sales/Maturities of investments | - | - | 71.94 Million | 211.8 Million | 63.12 Million | 25.25 Million |
| Other Investing Activities | 11 Thousand | -358 Thousand | 211.32 Thousand | 1.12 Million | 462.55 Thousand | 45.77 Million |
| Financing Cash Flow | 24.54 Million | 29.21 Million | 73.85 Thousand | 883.41 Thousand | 596 Thousand | 14 Thousand |
| Debt repayment | -24.5 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 37.85 Thousand | 29.21 Million | 73.85 Thousand | 883.41 Thousand | 435 Thousand | 13.55 Thousand |
| Other Financing Activities | 24.5 Million | 74 Thousand | 74 Thousand | 256 Thousand | 161 Thousand | 450.00 |
| Accounts receivables | 5.18 Million | 15.61 Million | -583.87 Thousand | -1.29 Million | -2.69 Million | -1.73 Million |
| Accounts payables | 8.65 Million | -7.64 Million | -1.29 Million | -9.12 Million | 1.03 Million | -8.87 Million |
| Inventory | - | - | -1.00 | -1.00 | 1.66 Million | 10.61 Million |
| Other working capital | -41.19 Million | 2.38 Million | 30.29 Million | -14.63 Million | -4.69 Million | -5.88 Million |
| Cash at beginning of period | 140.67 Million | 143.99 Million | 90.05 Million | 108.03 Million | 80.2 Million | 121.44 Million |
| Cash at end of period | 211.81 Million | 140.67 Million | 143.99 Million | 143.99 Million | 93.07 Million | 80.2 Million |
| Capital Expenditure | -754.55 Thousand | -357.79 Thousand | -828.01 Thousand | -4.89 Million | -289 Thousand | -1.24 Million |
| Effect of forex changes on cash | -20 Thousand | -416 Thousand | 350 Thousand | 877 Thousand | 129 Thousand | -190 Thousand |
| Net cash flow / Change in cash | 71.14 Million | -3.32 Million | 53.93 Million | 35.95 Million | 12.87 Million | -41.24 Million |
| Free Cash Flow | 46.63 Million | -32.28 Million | -15.49 Million | -146.32 Million | -45.44 Million | -45 Million |
BENH
2115
AWZ
DUOT
8013
1459